M-Amoxi Clav 62.5 mg

M-AMOXI CLAV 62.5 MG is a powder for oral suspension containing clavulanic acid (clavulanate potassium). This combination medication is commonly used for bacterial infections. It is manufactured by Mantra Pharma Inc. in Canada.

M-AMOXI CLAV 62.5 MG is typically used to treat bacterial infections. The combination of clavulanic acid and amoxicillin works to combat a wide range of bacterial strains. This medication is often prescribed for respiratory, urinary, and skin infections. It is important to consult a healthcare provider to determine if this medication is suitable for your specific condition.

Common effects of M-AMOXI CLAV 62.5 MG may include mild gastrointestinal discomfort, such as diarrhea or nausea. Some individuals may experience allergic reactions, though these are less common. If you experience severe or persistent side effects, it is advisable to seek medical attention.

M-AMOXI CLAV 62.5 MG should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

M-AMOXI CLAV 62.5 MG may interact with certain medications, including other antibiotics and blood thinners. It is also advisable to avoid alcohol while taking this medication, as it may increase the risk of side effects. Always consult your healthcare provider before starting any new medication.